Dividend Declaration

Click here - to use the wp menu builder

News Room

Less than 1 min.Read

By Investing Today

January 17, 2025

FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86

DIVIDEND DECLARATION
17 JANUARY 2025

The Board is pleased to declare an interim dividend of 2.0p per share, which will be paid on 14 March 2025. The shares will be quoted ex-dividend on 27 February 2025 and the record date for payment will be 28 February 2025.

For further information, please contact:

Company Secretary
Foresight Group LLP
Contact: Stephen Thayer Tel: 0203 667 8100

Investor Relations
Foresight Group LLP
Contact: Andrew James Tel: 0203 667 8181

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Net Asset Value(s)

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 17 January 2025

ThreeD Capital Inc. Completes Private Placement Financing

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering

Corporate Update

Lifecore Biomedical Announces Special Stockholder Meeting

Topics

ThreeD Capital Inc. Completes Private Placement Financing

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering

Corporate Update

Lifecore Biomedical Announces Special Stockholder Meeting

Mawson Infrastructure Group Inc. Appoints William C. Regan as Chief Financial Officer

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

XORTX Announces Change of Auditor

Related Articles

ThreeD Capital Inc. Completes Private Placement Financing

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering

Corporate Update

Lifecore Biomedical Announces Special Stockholder Meeting

Company

Headlines

ThreeD Capital Inc. Completes Private Placement Financing

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes Offering

Corporate Update

Newsletter